VNRX

SEC filing VNRX Obtains $9.9M Convertible Note Waiver from Lind, Avoids Default, Preserves Conversion Option at 90% of VWAP

10d ago

SEC filing VNRX Reduces Board to 7 Directors After Mickie Henshall Declines Re‑Election

17d ago

News VolitionRx anticipates first DETECSEPS patient in September as Q1 revenue rises to about $1M

17d ago

News VolitionRX GAAP EPS of -$0.97 misses by $0.26, revenue of $0.99M beats by $0.46M

18d ago

SEC filing VNRX Announces 1-for-20 Reverse Stock Split Approved by Shareholders, Effective April 28, 2026

34d ago

News Fortress’ Latest Private Debt Fund Seeks to Lure Insurance Firms

106d ago

News Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

133d ago

News Volition Sponsors Symposium at Veterinary Meeting and Expo

137d ago

News VolitionRx secures $2M financing through amended securities agreement; shares up

145d ago

News VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

145d ago

Scanner Unusual volume (z=12.1)

166d ago